Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2025

• Target Audience: endocrinologists, rheumatologists, primary care providers
• Sample video: contact me for sample video
• Information:

1. Overview

Course Date: 2025

2. Learning Objectives

Evaluate evolving definitions of osteoporosis and interpret complex DXA and Trabecular Bone Score (TBS) data to optimize patient assessment.

Diagnose and manage rare and genetic bone diseases, including early-onset osteoporosis with WNT1 mutations and Vitamin D dependent rickets.

Implement targeted screening and treatment approaches for underdiagnosed populations, specifically men and patients with anorexia nervosa.

Formulate evidence-based management strategies for patients experiencing adverse events or atypical femur fractures during osteoporosis therapy.

Assess the efficacy and safety considerations of parathyroid hormone analogs and other emerging therapeutics in bone health management.

3. Target Audience

Best for endocrinologists, rheumatologists, and primary care providers who want updates on osteoporosis management, DXA interpretation, and rare bone diseases.

4. Topics

01 Lessons from 50 Years of Osteoporosis – Evolving Definitions, DEXA, and Treatment Strategies

03 PTHrP in Non-Malignant Hypercalcemia – What PTHrP Level Warrants Malignancy Workup

04 Vitamin D Dependent Rickets Type 1A – Severe Complications from Delayed Treatment in a Pediatric Case

05 Immune Checkpoint Inhibitors – Rare Case of Hypoparathyroidism in Metastatic Endometrial Cancer

06 Osteoporosis in Men – Addressing Underdiagnosis, Targeted Screening, and Treatment Approaches

07 Atypical Fractures During Denosumab Therapy in Osteoporosis – Management Dilemmas

08 Osteoporosis With Atypical Femur Fracture – Navigating Postfracture Management Dilemmas

09 Bone Health in Rural Patients – Navigating Therapy Choices for Osteoporosis and Paget Disease

11 Adverse Events With Osteoporosis Therapies – Practical Strategies for Side Effect Management

12 Anorexia Nervosa and Premenopausal Osteoporosis – Diagnostic and Management Challenges

13 Osteoporosis Treatment Insights – Lessons from Bone Biopsy and Histomorphometry

14 Parathyroid Hormone Analogs in Osteoporosis – Efficacy, Anabolic Window, and Safety Considerations

15 Osteoporosis Assessment – Navigating DXA Quality, TBS, and Clinical Pitfalls

16 Perioprosthetic Fractures in Osteoporotic Patients – Diagnosis, Management, and Prevention